5-甲基-2-苯基噁唑-4-甲酰胺 | 51655-72-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 5-甲基-2-苯基噁唑-4-甲酰胺
• 英文名称: 4-Carbamyl-5-methyl-2-phenyloxazol
• 英文别名: 5-methyl-2-phenyl-oxazole-4-carboxylic acid amide；4-carbamoyl-5-methyl-2-phenyloxazole；4-Oxazolecarboxamide, 5-methyl-2-phenyl-；5-methyl-2-phenyl-1,3-oxazole-4-carboxamide
• CAS: 51655-72-2
• 化学式: C₁₁H₁₀N₂O₂
• mdl: MFCD01710015
• 分子量: 202.213
• InChiKey: XGEIAQCIGAIRAF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  69.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  5-甲基-2-苯基-4-噁唑甲酸乙酯 在 sodium hydroxide 、 氯化亚砜 、 氨 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 生成 5-甲基-2-苯基噁唑-4-甲酰胺
  参考文献：
  名称：

  Tarzia,G. et al., European Journal of Medicinal Chemistry, 1976, vol. 11, p. 263 - 270

  摘要：

  DOI：

文献信息

• Monoamino 2,4,5-trisubstituted oxazoles
  申请人：Gruppo Lepetit S.p.A.

  公开号：US04072689A1

  公开（公告）日：1978-02-07

  Pharmacologically active 2,4,5-trisubstituted oxazoles of the general formula ##STR1## wherein A is cyclohexyl, thienyl or a group of the formula ##STR2## in which R represents one to three substituents each independently selected from the group consisting of hydrogen, lower alkyl, halo, halo-lower alkyl, lower alkoxy, nitro, cyano, amino, carbamoyl, acetamino or carboxy; one of the R.sub.1 and R.sub.2 groups is a lower alkyl group and the other is an amido group, ##STR3## wherein R.sub.3 is selected from the group consisting of hydrogen, lower alkyl, lower alkenyl, cycloalkyl, phenyl, substituted phenyl, phenyl-lower alkyl, hydroxy-lower alkyl, lower acyloxy-lower alkyl, hydroxy, amino, lower alkylideneamino, cycloalkylideneamino, benzylideneamino and R.sub.4 is selected from hydrogen, lower alkyl, lower alkenyl, cycloalkyl, phenyl, substituted phenyl, phenyl-lower alkyl, hydroxy-lower alkyl, lower acyloxy-lower alkyl, or R.sub.3 and R.sub.4 taken together with the nitrogen atom may also form a 5- to 7-membered hetero ring which may contain one other hetero atom selected from N, O and S. The compounds have antiinflammatory activity.

  药理活性的2,4,5-三取代噁唑的通式为##STR1##其中A为环己基，噻吩基或公式##STR2##的基团，其中R代表从氢，低级烷基，卤素，卤素-低级烷基，低级烷氧基，硝基，氰基，氨基，氨基甲酰基，乙酰氨基或羧基选择的一个至三个取代基，R.sub.1和R.sub.2基团中的一个是低级烷基基团，另一个是酰胺基团，##STR3##其中R.sub.3选择自氢，低级烷基，低级烯基，环烷基，苯基，取代苯基，苯基-低级烷基，羟基-低级烷基，低级酰氧基-低级烷基，羟基，氨基，低级烷基亚胺基，环烷基亚胺基，苄亚胺基和R.sub.4选择自氢，低级烷基，低级烯基，环烷基，苯基，取代苯基，苯基-低级烷基，羟基-低级烷基，低级酰氧基-低级烷基，或R.sub.3和R.sub.4与氮原子一起也可以形成一个5-至7-成员的杂环，其中可能包含另一个从N，O和S选择的杂原子。这些化合物具有抗炎活性。
• TARZIA G.; SCHIATTI P.; SELVA D.; FAVARA D.; CERIANI S., EUR. J. MED. CHEM., 1976, 11, NO 3, 263-270
  作者：TARZIA G.、 SCHIATTI P.、 SELVA D.、 FAVARA D.、 CERIANI S.

  DOI：——

  日期：——
• PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS
  申请人：Lead Discovery Center GmbH

  公开号：EP2609091A1

  公开（公告）日：2013-07-03
• US4072689A
  申请人：——

  公开号：US4072689A

  公开（公告）日：1978-02-07
• [EN] PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS<br/>[FR] COMPOSÉS PHARMACEUTIQUEMENT ACTIFS EN TANT QU'INHIBITEURS DE AXL
  申请人：LEAD DISCOVERY CENTER GMBH

  公开号：WO2012028332A1

  公开（公告）日：2012-03-08

  The present invention relates to 1-nitrogen-heterocyclic-2-carboxamides of general formula (I): and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the treatment and/or prevention of Axl receptor tyrosine kinase subfamily induced disorders, including cancer and primary tumor metastases, and pharmaceutical compositions containing at least one of said 1-nitrogen-heterocyclic-2-carboxamide derivatives and/or pharmaceutically acceptable salts thereof.